Long Term Safety of Sativex Oromucosal Spray (Sativex®; Nabiximols) as Adjunctive Therapy in Patients With Uncontrolled Persistent Chronic Cancer Related Pain
Clinical trial NCT01337089 · COMPLETED
Trial details
- NCT number
- NCT01337089
- Sponsor
- Jazz Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-01-19
- Primary completion
- 2016-01-27
- Enrollment
- 660
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.